There is one small pilot study in humans (examining knee pain, where 7 of 12 participants reported sustained improvement beyond 6 months) and a 2025 safety study confirming BPC-157 was well tolerated in healthy adults
This medication is administered through injection using a syringe
Thus, scientists must note that unanticipated reactions may emerge as research progresses
If you are an established patient, you have already fulfilled this requirement
Across the board, there is no way to know about the right dose, purity, potential contaminants, and the impact of long-term use in people
It is a small synthetic molecule, not a peptide